HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Dunn, M. E. Search for Related Content PubMed PubMed Citation Articles by Dunn, M. E.

Dr Dunn is a consultant for Lilly ICOS LLC and Pfizer Inc.

Address correspondence to Marian E. Dunn, PhD, Director, Center for Human Sexuality, Department of Psychiatry, State University of New York Down-state Medical Center, 450 Clarkson Ave, Brooklyn, NY 11203-2098. E-mail: mdunn77{at}aol.com

The new modes of pharmacologic therapy give health care practitioners an unprecedented opportunity to treat patients with erectile dysfunction (ED), an undiagnosed and underreported condition. Yet even with a portfolio of effective treatment modalities, such as phosphodiesterase type 5 (PDE5) inhibitors, nonpharmacologic interventions should be considered as means to support and augment the effects of these agents. Of equal value—and necessity—is the involvement of the man's partner in both the assessment and treatment processes. Because men see the primary care physician's office as a natural and expected place in which to address issues of sexual health, those healthcare professionals who are prepared to initiate discussion of ED can offer patients and their partners the possibility of effective and enduring treatment success and the restoration of a satisfying relationship.